| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 11/07/2002 | WO2001093888A3 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs |
| 11/07/2002 | WO2001092476A3 In vitro tissue test system |
| 11/07/2002 | WO2001048187A9 A molecular switch for regulating mammalian gene expression |
| 11/07/2002 | WO2001037881A9 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 11/07/2002 | WO2001021220A9 Bioprosthetic heart valves |
| 11/07/2002 | US20020166134 Cardiomyocytes with enhanced proliferative potenial, and methods for preparing and using same |
| 11/07/2002 | US20020165371 Compositions and methods for the therapy and diagnosis of breast cancer |
| 11/07/2002 | US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders |
| 11/07/2002 | US20020165190 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same |
| 11/07/2002 | US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 11/07/2002 | US20020165173 T-cell factor (TCF); constructs having multiple repeats of a TCF-binding element linked to a promoter and used to express genes encoding therapeutic proteins; drug screening for anticancer agents that suppress transcription |
| 11/07/2002 | US20020165166 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 11/07/2002 | US20020164802 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer |
| 11/07/2002 | US20020164799 Expression vector coding proteins for use in the treatment of cancer |
| 11/07/2002 | US20020164794 Pluripotent somatic stem cells for use in regenerative medicine |
| 11/07/2002 | US20020164791 Primitive neural stem cells and method for differentiation of stem cells to neural cells |
| 11/07/2002 | US20020164790 Activating growth of lung alveolar surface; obtain lung stem cells, graft into defective lung, monitor propagation of lung alveolar surface |
| 11/07/2002 | US20020164767 DNA encoding the human serine protease C-E |
| 11/07/2002 | US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer |
| 11/07/2002 | US20020164384 Aquatic animal treatment method and composition containing pimenta extract |
| 11/07/2002 | US20020164378 Use of bioactive fraction from cow urine distillate ('Go-mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 11/07/2002 | US20020164349 Induction apoptosis; west nile virus therapy |
| 11/07/2002 | US20020164343 Administering cold carbon dioxide; heating; precipitation |
| 11/07/2002 | US20020164331 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 11/07/2002 | US20020164321 Compositions and methods for treating retroviral infections |
| 11/07/2002 | US20020164313 Therapy for muscular dystrophy |
| 11/07/2002 | US20020164312 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 11/07/2002 | US20020164309 Cell culture of nervous system cells |
| 11/07/2002 | US20020164308 Embryonic stem cells and neural progenitor cells derived therefrom |
| 11/07/2002 | US20020164307 Replacement of damage cells |
| 11/07/2002 | US20020164305 Integrin fusion protein; binding to antibodies |
| 11/07/2002 | DE10126137C1 In vitro preparation of cells, tissues and organs, useful e.g. as wound dressing, as model or implant, by growing on resorbable matrix of hydrolyzed silane |
| 11/07/2002 | DE10120505A1 Verwendung von stimulierten mononukleären Zellen des peripheren Blutes zur Behandlung von Krebserkrankungen Use of stimulated peripheral blood mononuclear cells for the treatment of cancer |
| 11/07/2002 | CA2454601A1 Microparticle protection of therapeutic agents |
| 11/07/2002 | CA2454276A1 Neural progenitor cells |
| 11/07/2002 | CA2446079A1 Modulators of elastase inhibitor secretion |
| 11/07/2002 | CA2445945A1 Modified organs and cells for xenotransplantation |
| 11/07/2002 | CA2445593A1 Genetically modified yt cell line and use thereof |
| 11/07/2002 | CA2445382A1 Method for generating highly active human dendritic cells from monocytes |
| 11/07/2002 | CA2445266A1 Foot and mouth disease virus vaccine |
| 11/07/2002 | CA2445110A1 Tridimensional biocompatible support structure for bioartificial organs and uses thereof |
| 11/07/2002 | CA2444911A1 Fusion molecules and methods for treatment of immune diseases |
| 11/07/2002 | CA2438223A1 Carboxylic acid such as citric acid for desinfecting or enhacing the production of blood products such as plasma, cryoprecipitate or/and platelet |
| 11/06/2002 | EP1254956A2 Novel osteoinductive compositions |
| 11/06/2002 | EP1254953A1 Maturation-promoting agent for immature dendritic cells |
| 11/06/2002 | EP1254952A1 Cells capable of differentiating into heart muscle cells |
| 11/06/2002 | EP1254663A1 Anti-virus agent |
| 11/06/2002 | EP1254231A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 11/06/2002 | EP1254229A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 11/06/2002 | EP1254222A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 11/06/2002 | EP1254220A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 11/06/2002 | EP1254212A2 Methods of preparing and using a viral vector library |
| 11/06/2002 | EP1254211A1 Cell production |
| 11/06/2002 | EP1254169A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 11/06/2002 | EP1253966A2 Substances and agents for positively influencing collagen |
| 11/06/2002 | EP1253948A2 Gene therapy for treating ocular-related disorders |
| 11/06/2002 | EP1253946A2 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 11/06/2002 | EP1253941A1 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 11/06/2002 | EP1253932A2 Botulinum toxin pharmaceutical compositions |
| 11/06/2002 | EP1253930A2 Method and compositions for treating hepatocellular cancer |
| 11/06/2002 | EP1253928A2 Novel haptotactic peptides |
| 11/06/2002 | EP1253830A1 Pharmaceutical composition for muscular anabolism |
| 11/06/2002 | EP1109818B1 Phosphoepoxides, method for making same and uses |
| 11/06/2002 | EP0726758B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 11/06/2002 | CN1378591A Bacterial protection |
| 11/06/2002 | CN1378458A Use of TGF-beta and growth factors in treatment and prevention of diseases of intestinal mucosa |
| 11/06/2002 | CN1377889A Protein for causing sperm not wandering prepared from india worm lizard body cavity liquid |
| 11/06/2002 | CN1377704A Anti-disease silk increasing agent for silk worm |
| 11/06/2002 | CN1377694A Chinese patented medicine for preventing and curing cancer |
| 11/06/2002 | CN1377685A Chinese medicine composition for curing chloasma |
| 11/06/2002 | CN1377682A Bone-setting pain stopping paste |
| 11/06/2002 | CN1377668A Pure traditional Chinese medicinal preparation for curing child's epilepsy disease and its preparing method |
| 11/06/2002 | CN1377666A Medicine for curing cholecystitis and its preparing method |
| 11/06/2002 | CN1377654A Biological wall breaking technology for rape melissa powder |
| 11/06/2002 | CN1377653A Medical paste for burn |
| 11/06/2002 | CN1377652A Method for preparing micro element concentrated mineral liquid |
| 11/06/2002 | CN1377586A Sobering-up and drunkenness-preventing liver protective beverage containing dehydrogenase |
| 11/06/2002 | CN1093881C Process for preparation of immunogens or diagnostic reagents, and method for obtaining immunogens or diagnostic reagents |
| 11/06/2002 | CN1093764C Medical liquor for nourishing kindney |
| 11/05/2002 | US6476290 Transgenic tilapia comprising a humanized insulin gene |
| 11/05/2002 | US6476214 Inhibition of cytokine production |
| 11/05/2002 | US6476197 Polypeptides having interferon-γ inducing activity |
| 11/05/2002 | US6476005 Oral and injectable nutritional composition |
| 11/05/2002 | US6476002 Treatment of chronic inflammatory diseases with CM101/GBS toxin |
| 11/05/2002 | US6476001 Facilitation of repair of neural injury with CM101/GBS toxin |
| 11/05/2002 | US6475997 Methods of stimulating phagocytosis |
| 11/05/2002 | US6475996 Use of a vector expressing DNA polymerase β as medicine |
| 11/05/2002 | US6475984 Administration of leptin |
| 11/05/2002 | US6475756 Development of viruses resistant to inactivation by the human complement system |
| 11/05/2002 | US6475718 Genetically engineered eukaryotic cell; for prevention of viral infections; viricides |
| 11/05/2002 | US6475547 Immunoglobulin-rich milk, production and use thereof |
| 11/05/2002 | US6475532 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof |
| 11/05/2002 | US6475511 Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format |
| 11/05/2002 | US6475485 Two novel human cathepsin proteins |
| 11/05/2002 | US6475483 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens for treating autoimmune diseases |
| 11/05/2002 | US6475482 Genetically modified tumor-targeted bacteria with reduce virulence |
| 11/05/2002 | US6475481 Purging of stem cell products |
| 10/31/2002 | WO2002086510A1 Method and composition for skin grafts |
| 10/31/2002 | WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene |
| 10/31/2002 | WO2002086154A2 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages |